{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:09:57Z","timestamp":1786990197209,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2022 R1A2C4001769"],"award-info":[{"award-number":["NRF-2022 R1A2C4001769"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.hpb.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:21:26Z","timestamp":1771460486000},"page":"796-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive molecular-clinical profiling of cholangiocarcinoma according to pathologic subtypes"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-8009","authenticated-orcid":false,"given":"Keun Soo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-9127","authenticated-orcid":false,"given":"Yoo Na","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofic","family":"Mounajjed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-524X","authenticated-orcid":false,"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-0636","authenticated-orcid":false,"given":"Min Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh J.","family":"Borad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.02.007_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-2-10","article-title":"Worldwide trends in mortality from biliary tract malignancies","volume":"2","author":"Patel","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2026.02.007_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.14701\/ahbps.21-173","article-title":"Changing incidence and survival of intrahepatic cholangiocarcinoma based on surveillance, epidemiology, and end results database (2000-2017)","volume":"26","author":"Ali","year":"2022","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.hpb.2026.02.007_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hpb.2026.02.007_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hpb.2026.02.007_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hpb.2026.02.007_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0b013e31802b34b6","article-title":"Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type","volume":"31","author":"Aishima","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.hpb.2026.02.007_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.hpb.2026.02.007_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.hpb.2018.07.021","article-title":"Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma","volume":"21","author":"Akita","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.02.007_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3350\/cmh.2021.0287","article-title":"Intrahepatic cholangiocarcinoma: tumour heterogeneity and its clinical relevance","volume":"28","author":"Komuta","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hpb.2026.02.007_bib10","doi-asserted-by":"crossref","first-page":"154126","DOI":"10.1016\/j.prp.2022.154126","article-title":"Impact of small duct- and large duct type on survival in patients with intrahepatic cholangiocarcinoma: results from a German tertiary center","volume":"238","author":"Kinzler","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.hpb.2026.02.007_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hpb.2019.10.009","article-title":"Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes","volume":"22","author":"Chung","year":"2020","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.02.007_bib12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2026.02.007_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2026.02.007_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2026.02.007_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2026.02.007_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hpb.2026.02.007_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","article-title":"Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach","volume":"13","author":"Ahn","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.hpb.2026.02.007_bib18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/hep.25587","article-title":"Mucin-producing cholangiocarcinoma might derive from biliary tree stem\/progenitor cells located in peribiliary glands","volume":"55","author":"Cardinale","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2026.02.007_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2105-15-224","article-title":"MAP-RSeq: Mayo analysis pipeline for RNA sequencing","volume":"15","author":"Kalari","year":"2014","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.hpb.2026.02.007_bib20","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.hpb.2026.02.007_bib21","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol"},{"key":"10.1016\/j.hpb.2026.02.007_bib22","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: quality control of RNA-seq experiments","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib24","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2011-12-8-r72","article-title":"TopHat-Fusion: an algorithm for discovery of novel fusion transcripts","volume":"12","author":"Kim","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.hpb.2026.02.007_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/bioinformatics\/bts053","article-title":"JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal\/tumour paired next-generation sequencing data","volume":"28","author":"Roth","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nmeth.1628","article-title":"CREST maps somatic structural variation in cancer genomes with base-pair resolution","volume":"8","author":"Wang","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.hpb.2026.02.007_bib28","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib29","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/bioinformatics\/btu363","article-title":"PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hpb.2026.02.007_bib30","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.hpb.2026.02.007_bib31","doi-asserted-by":"crossref","first-page":"W102","DOI":"10.1093\/nar\/gky406","article-title":"Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hpb.2026.02.007_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/j.hpb.2026.02.007_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2026.02.007_bib34","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1245\/s10434-023-14833-1","article-title":"Impact of tumor subclassifications for identifying an appropriate surgical strategy in patients with intrahepatic cholangiocarcinoma","volume":"31","author":"Kinoshita","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.02.007_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030445","article-title":"Should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? A collaborative Korea-Japan study","volume":"13","author":"Kang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hpb.2026.02.007_bib36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.gassur.2024.03.029","article-title":"Surgical strategy for incidental intrahepatic cholangiocarcinoma in terms of lymph node dissection","volume":"28","author":"Kim","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2026.02.007_bib37","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hpb.2026.02.007_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.hpb.2026.02.007_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.02.007_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.hpb.2026.02.007_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MOG.0000000000000171","article-title":"Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma","volume":"31","author":"Borad","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.hpb.2026.02.007_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.21037\/jgo.2016.09.01","article-title":"Molecular profiling of biliary tract cancer: a target rich disease","volume":"7","author":"Jain","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2026.02.007_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.hpb.2026.02.007_bib44","doi-asserted-by":"crossref","first-page":"46750","DOI":"10.18632\/oncotarget.8775","article-title":"The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets","volume":"7","author":"Chong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2026.02.007_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3350\/cmh.2016.0105","article-title":"Histopathology of a benign bile duct lesion in the liver: morphologic mimicker or precursor of intrahepatic cholangiocarcinoma","volume":"22","author":"Lee","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hpb.2026.02.007_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamasurg.2021.5679","article-title":"Association of KRAS variant subtypes with survival and recurrence in patients with surgically treated intrahepatic cholangiocarcinoma","volume":"157","author":"Zhou","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2026.02.007_bib47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2023.02.045","article-title":"Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects","volume":"164","author":"Cho","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2026.02.007_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","article-title":"Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma","volume":"36","author":"Javle","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.02.007_bib49","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:37:57Z","timestamp":1780501077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1365182X26000572"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.02.007","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive molecular-clinical profiling of cholangiocarcinoma according to pathologic subtypes","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}